Double maintains 2 strategies that include SMMT - Summit Therapeutics, Inc.
Current Value
$21.241 Year Return
Current Value
$21.241 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DFIP | -0.08% | $920.81M | 0.11% |
| BSCS | -0.11% | $2.62B | 0.1% |
| SCHQ | 0.17% | $752.08M | 0.03% |
| IBMO | 0.19% | $526.03M | 0.18% |
| SLQD | -0.20% | $2.28B | 0.06% |
| BBAG | 0.23% | $1.28B | 0.03% |
| GNMA | -0.24% | $367.52M | 0.1% |
| IBMS | -0.25% | $88.27M | 0.18% |
| GSY | 0.25% | $2.86B | 0.22% |
| BIV | -0.34% | $23.30B | 0.03% |
| BNO | -0.34% | $103.86M | 1% |
| TLH | -0.35% | $11.41B | 0.15% |
| USL | -0.36% | $42.30M | 0.85% |
| KCCA | 0.37% | $105.90M | 0.87% |
| SHYM | -0.38% | $354.58M | 0.35% |
| SMB | 0.39% | $274.79M | 0.07% |
| PULS | 0.40% | $11.70B | 0.15% |
| BKAG | 0.41% | $1.90B | 0% |
| SUB | -0.43% | $9.91B | 0.07% |
| JBND | -0.44% | $2.31B | 0.25% |
Finnhub
NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. . Such investors are advised to contact Danielle Peyton at...
Yahoo
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. Analysts at H.C. Wainwright reaffirmed their Buy rating on Summit Therapeutics Inc. (NASDAQ:SMMT) on June 2, citing a $44 price target. The analysts emphasized how Summit Therapeutics’ medication ivonescimab holds the potential to emerge as […]
SeekingAlpha
Instil Bio's pipeline includes AXN-2510/IMM2510, a differentiated PD-L1xVEGF bispecific antibody with upcoming data in H2'25. Click here to read more.
Finnhub
Summit Therapeutics Inc. added to Russell Midcap Growth Index...
Finnhub
Summit Therapeutics Inc. dropped from Russell 2000 Dynamic Index...
Yahoo
REDWOOD CITY, Calif. & MIAMI, June 30, 2025--Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers and Summit Therapeutics Inc. (Nasdaq: SMMT), a biopharmaceutical oncology company focused on patient-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs, today announced the companies have entered into a clinical
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 47.25% | $4.84B | 0.35% |
| IBB | 43.61% | $5.28B | 0.45% |
| GNOM | 41.91% | $44.38M | 0.5% |
| PBE | 39.72% | $223.86M | 0.58% |
| BBH | 37.70% | $329.37M | 0.35% |
| PTH | 37.07% | $100.70M | 0.6% |
| FBT | 36.94% | $1.01B | 0.54% |
| ARKG | 36.93% | $1.02B | 0.75% |
| RDTE | 36.65% | $137.58M | 0.97% |
| HEGD | 36.54% | $424.85M | 0.88% |
| IWC | 36.20% | $817.74M | 0.6% |
| IWO | 36.07% | $11.53B | 0.24% |
| PINK | 35.00% | $129.96M | 0.5% |
| KJUL | 34.69% | $119.28M | 0.79% |
| QQQJ | 34.30% | $618.04M | 0.15% |
| RUNN | 33.89% | $363.30M | 0.58% |
| IWM | 33.62% | $63.18B | 0.19% |
| SCHA | 33.41% | $17.26B | 0.04% |
| VTWO | 33.41% | $12.58B | 0.07% |
| ISCG | 33.35% | $679.46M | 0.06% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -25.46% | $99.49M | 0.59% |
| VIXY | -24.25% | $165.58M | 0.85% |
| BTAL | -21.94% | $295.67M | 1.43% |
| XONE | -15.39% | $585.85M | 0.03% |
| IVOL | -13.67% | $348.25M | 1.02% |
| ULST | -10.99% | $658.54M | 0.2% |
| UTWO | -10.86% | $379.27M | 0.15% |
| TPMN | -10.18% | $30.70M | 0.65% |
| GBIL | -9.79% | $6.37B | 0.12% |
| UNG | -9.60% | $388.31M | 1.06% |
| USFR | -9.56% | $18.59B | 0.15% |
| XHLF | -9.53% | $1.73B | 0.03% |
| JMST | -9.15% | $4.06B | 0.18% |
| SPTS | -9.08% | $5.77B | 0.03% |
| IBTH | -7.98% | $1.60B | 0.07% |
| IBTG | -7.89% | $1.92B | 0.07% |
| VGSH | -7.80% | $22.77B | 0.03% |
| BIL | -7.66% | $42.84B | 0.1356% |
| BILS | -7.00% | $3.83B | 0.1356% |
| IBTI | -6.70% | $1.06B | 0.07% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RLAY | 52.29% | $603.49M | -45.60% | 0.00% |
| BNTX | 51.84% | $25.84B | +36.50% | 0.00% |
| XNCR | 43.87% | $574.35M | -55.81% | 0.00% |
| CRNX | 41.05% | $2.66B | -37.57% | 0.00% |
| IMNM | 39.65% | $736.56M | -27.65% | 0.00% |
| ZWS | 38.75% | $6.29B | +28.20% | 0.93% |
| CSW | 38.27% | $4.87B | +8.46% | 0.33% |
| DNLI | 37.94% | $2.03B | -35.83% | 0.00% |
| RCUS | 36.89% | $885.20M | -42.94% | 0.00% |
| ELVN | 36.54% | $1.16B | -9.45% | 0.00% |
| APGE | 36.17% | $2.63B | +15.83% | 0.00% |
| REGN | 35.53% | $57.75B | -48.80% | 0.16% |
| ACLX | 35.53% | $3.56B | +21.48% | 0.00% |
| ALEC | 35.38% | $141.99M | -67.28% | 0.00% |
| RARE | 35.13% | $3.43B | -11.47% | 0.00% |
| IDYA | 34.69% | $1.85B | -37.37% | 0.00% |
| EYPT | 34.09% | $657.15M | +19.23% | 0.00% |
| MGNX | 34.02% | $79.49M | -69.27% | 0.00% |
| TVTX | 33.93% | $1.31B | +81.83% | 0.00% |
| VKTX | 33.76% | $3.00B | -48.25% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RRGB | -16.63% | $114.40M | -2.57% | 0.00% |
| CME | -8.24% | $99.25B | +39.75% | 3.87% |
| ARRY | -6.99% | $1.01B | -31.05% | 0.00% |
| MSIF | -6.91% | $756.27M | +33.83% | 7.70% |
| VSA | -6.74% | $8.76M | -18.25% | 0.00% |
| PPC | -6.14% | $10.79B | +32.45% | 0.00% |
| TEF | -4.72% | $30.02B | +27.27% | 6.13% |
| TV | -4.37% | $995.04M | -14.12% | 0.00% |
| AMCX | -4.23% | $275.85M | -34.68% | 0.00% |
| SHLS | -3.86% | $880.18M | -12.25% | 0.00% |
| CBOE | -3.67% | $24.29B | +35.36% | 1.09% |
| EHC | -3.56% | $12.14B | +40.73% | 0.70% |
| PULM | -3.49% | $24.14M | +230.50% | 0.00% |
| MCK | -3.37% | $90.90B | +24.44% | 0.39% |
| VRSN | -3.18% | $27.14B | +64.27% | 0.27% |
| CL | -3.17% | $74.59B | -4.24% | 2.20% |
| CABO | -3.12% | $795.04M | -59.44% | 6.27% |
| ENPH | -3.02% | $5.37B | -57.28% | 0.00% |
| UVV | -2.85% | $1.42B | +20.13% | 5.63% |
| AQB | -2.69% | $2.87M | -53.40% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| UNFI | 0.01% | $1.39B | +81.30% | 0.00% |
| STVN | 0.02% | $6.77B | +37.78% | 0.25% |
| IMNN | 0.03% | $15.87M | -37.00% | 0.00% |
| CF | -0.06% | $14.98B | +30.58% | 2.14% |
| KVUE | -0.08% | $40.26B | +14.97% | 3.90% |
| GHG | 0.15% | $140.87M | -14.57% | 0.00% |
| CCEC | -0.20% | $1.02B | +3.91% | 2.54% |
| STG | -0.24% | $30.47M | -21.87% | 0.00% |
| QSR | 0.28% | $22.25B | -1.15% | 3.55% |
| BTCT | -0.35% | $22.63M | +43.33% | 0.00% |
| FYBR | -0.36% | $9.12B | +39.78% | 0.00% |
| EVGO | 0.40% | $473.61M | +50.21% | 0.00% |
| FSLR | 0.46% | $17.48B | -24.81% | 0.00% |
| NAT | 0.52% | $552.67M | -34.42% | 10.99% |
| MNOV | 0.53% | $62.29M | -9.29% | 0.00% |
| HRB | -0.55% | $7.47B | +1.23% | 2.70% |
| DAR | -0.60% | $6.03B | +2.45% | 0.00% |
| NXTC | 0.62% | $12.23M | -70.93% | 0.00% |
| HIHO | 0.63% | $7.26M | -20.67% | 4.19% |
| OMCL | 0.63% | $1.40B | +14.41% | 0.00% |
